Botulinum Toxin Market Size Share and Industry Outlook to 2028

SKU: DMPH2832 | Last Updated On: Jan 06 2022 | No. of Pages: 180 | Available Formats

> Global Botulinum Toxin Market Expected to reach a high CAGR By 2028: DataM Intelligence

Global Botulinum Toxin Market is segmented By Type (Botulinum toxin type A, Botulinum toxin type B, Botulinum toxin type C, Botulinum toxin type D, Botulinum toxin type E, Botulinum toxin type F, Botulinum toxin type G), By Application (Cosmetic Applications (Glabellar lines, Lateral canthal lines, Forehead Lines, Other), Non-Cosmetic Applications (Dystonia, Chronic migraine, Ophthalmologic disorders, Other)), By End-use (Hospital, Dermatology Clinics, Spas & cosmetic centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

The Global "Botulinum Toxin Market" is estimated to reach at a CAGR during the forecast period (2021-2028).  

Botulinum toxin is a neurotoxin produced by anaerobic bacteria known as Clostridium botulinum. Botulinum toxin is widely used for aesthetic purposes. Heavy investment in R&D projects to develop the therapeutic use of botulinum toxin is creating opportunities for the expansion of its application area in near future. 

Source: DataM Intelligence Analysis (2020)

Market Dynamics

The global botulinum toxin market growth is driven by the growing patient preference towards non-invasive or minimally treatments coupled with the development of novel products will thus accelerate the market growth.

Rising aesthetic consciousness and a number of non-invasive cosmetic procedures is expected to drive the growth in the forecast period

The botulinum toxin market is primarily driven by rising aesthetic consciousness and a number of non-invasive cosmetic procedures. According to the recent data of the American Society of Plastic Surgeons (ASPS), in 2018 among the 15.9 million cosmetic minimally-invasive procedures performed in the United States, Botulinum Toxin Type A tops the list with 7.44 million procedures. Many advanced non-surgical and minimally invasive aesthetic procedures were developed at the beginning of the 21st century. The increasing quality of care improved professional services, and the availability of minimally invasive surgeries by highly qualified aesthetic surgeons have contributed to the growth of procedural volume.

Furthermore, the aging population, rising incidence of aesthetic problems such as lateral canthal lines, crow’s feet and introduction of cost-effective aesthetic products are also boosting the botulinum toxin market demand. The focus of market players to develop and add new products to cosmetic procedures will further contribute to the market growth significantly.

Increase in the prevalence of spasticity and cervical dystonia, expected to drive the market growth

An increase in the prevalence of spasticity and cervical dystonia and the number of cases of migraine is expected to drive the botulinum toxin market during the forecast period. The surge in the rate of adoption of non-surgical botulinum toxin procedures, due to their noninvasive or minimally invasive nature, is boosting the botulinum toxin market. The rise in the worldwide geriatric population and incidences of aesthetic issues, such as crow’s foot and lateral canthal lines, is a key factor that is anticipated to propel the botulinum toxin market during the forecast period.

Side effects of available products are likely to hinder the market growth

However, the side effects of available products, lack of reimbursement policies supporting cosmetic procedures, and the high cost of the products can limit the adoption rate of the botulinum toxin market during the forecast period.

Opportunities:

 

 

COVID-19 Impact Analysis

Botulinum toxins are potent neurotoxins that can induce paralysis of muscle and acute respiratory arrest in humans. However, a mild dose of the purified form of botulinum toxins has been known to attenuate chronic cough, dyspnoea, pneumonia, acute respiratory failure, abnormal circulation, cardiac defects and various neurological deficits that have been recognized as the prominent clinical symptoms of COVID-19. This signifies the therapeutic uses of botulinum toxins against pulmonary failure, cardiac arrest and neurological deficits, and emphasizes the rationality for the possible use of botulinum toxins to prevent infection and manage COVID-19. Thus, the therapeutic nature of botulinum toxins in the treatment of COVID-19 will drive its market.

Segment Analysis

Botulinum toxin type A, the segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Botulinum toxin type A is segment is expected to maintain its dominance throughout the forecast period. Various products of Botulinum toxin type A are commercially available in the market which includes leading brands such as Botox and Dysport. Botox has an aesthetic application in moderate and severe glabellar lines removal and therapeutic application in treating severe primary axillary hyperhidrosis, blepharospasm, and cervical dystonia. Similarly, Xeomin is used for the removal of glabellar lines and the treatment of cervical dystonia and blepharospasm in some countries. However, it is observed that these products have few side effects such as allergic reactions, rash, nausea, neck, and back pain. BNTA products are also quite expensive and involve high expenses while performing surgical procedures. Hence, such factors are hindering the growth of the market.   

The cosmetic applications are expected to dominate the botulinum toxin market during the forecast period

There is a rising demand for aesthetic appearance among individuals that have created a subsequent demand for botulinum toxin procedures around the world. The concerns of people regarding their appearance are gradually on the increase, both in the developed and the developing world; thus, there is an increase in the number of cosmetic surgeries done, annually.

According to the International Society of Aesthetic Plastic Surgery 2018 report, there has been an increase in botulinum toxin procedures worldwide by 17.4% in 2018 compared to 2017. The botulinum toxin injection for the treatment of wrinkles is one of the most frequently performed cosmetic procedures worldwide, and it is one of the most common entry procedures for clinicians who seek to incorporate aesthetic treatments into their practice. Moreover, the effects of the botulinum toxin take about two weeks to develop and usually last three to four months fully. Further injections need to be given to sustain the effects for a longer period, and recurring revenue from injectable botulinum toxin encourages beauty clinics and medical practitioners to continue to recommend it.

Source: DataM Intelligence Analysis (2020)

Geographical Analysis

North America region holds the largest market share global botulinum toxin market

North America region is dominating the global botulinum toxin market accounted for the largest market share in 2020. Medical aesthetic technology has advanced rapidly over the last two decades in the United States. The highly advanced technologies have offered a wide range of products and solutions to patients seeking medical assistance. ​

According to the American Society for Aesthetic Plastic Surgery in 2018, 1,801,033 procedures had been performed with botulinum toxin, and it was the number one non-surgical procedure found in 2018. Out of the total procedures, 1,638,940 were considered for females and 162,093 for males. ​

There is also increased competition in the US botulinum toxin market that is set to increase with the launch of Jeuveau. Evolus Inc. in 2019, received the US FDA approval for its lead product, Jeuveau, for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults. Similarly, Daewoong pharmaceutical, in 2019, also officially launched Nabota, its botulinum toxin (BTX) strain, in the United States.

Source: DataM Intelligence Analysis (2020)

Competitive Landscape

The Botulinum Toxin market is moderately competitive with the presence of local as well as global companies.  Some of the key players which are contributing to the growth of the market include Allergan, Eisai Co., Ltd, Hugel, Inc., Hugh Source International Ltd., Ipsen, Medytox, Inc., Merz Pharma, Evolus, Inc., AbbVie, Revance Therapeutics, Inc. among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the botulinum toxin market globally.    

Botulinum Toxin Market Key Companies to Watch

Allergan Plc.

Overview: Allergan plc, incorporated on May 16, 2013, is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter (OTC) pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US General Medicine and International. The US Specialized Therapeutics segment includes sales relating to branded products within the United States, including Medical Aesthetics, Medical Dermatology, Eye Care, Neurosciences and Urology therapeutic products.

Product Portfolio: The Company’s portfolio is comprised of pharmaceutical products of specialties for ophthalmologic care, neuromuscular, dermatological and urologic medical devices primarily facial aesthetics products, breast plastic products.

Key Development: In September 2018, Allergan acquired Bonti Inc, a biotechnology company that focused on the commercialization and development of a novel and fast-acting neurotoxin program for therapeutic and aesthetic applications. This acquisition enabled Allergan to obtain Bonti’s two pipeline botulinum neurotoxin as well as expand its business portfolio and strengthen its market position.

Why Purchase the Report?

  • Visualize the composition of the botulinum toxin market segmentation by type, application, end-use, and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in the botulinum toxin market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of botulinum toxin market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global botulinum toxin market report would provide access to an approx. 61 market data table, 56 figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Botulinum Toxin Market - By Type

  • Botulinum toxin type A
  • Botulinum toxin type B
  • Botulinum toxin type C
  • Botulinum toxin type D
  • Botulinum toxin type E
  • Botulinum toxin type F
  • Botulinum toxin type G

Global Botulinum Toxin Market - By Application

  • Cosmetic Applications
    • Glabellar lines
    • Lateral canthal lines (crow's feet)
    • Forehead Lines
    • Other
  • Non-Cosmetic Applications
    • Dystonia
    • Chronic migraine
    • Ophthalmologic disorders
    • Other

Global Botulinum Toxin Market - By End-use

  • Hospital
  • Dermatology Clinics
  • Spas & cosmetic centers

Global Botulinum Toxin Market - By Region

  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Trending Topics

Intraocular Melanoma Market

Liver Cancer Therapeutics Market

Appendix Cancer Drugs Market

Table of Contents

  1. Global Botulinum Toxin Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Botulinum Toxin Market – Market Definition and Overview

  3. Global Botulinum Toxin Market – Executive Summary

    1. Market Snippet By Type
    2. Market snippet by Application
    3. Market Snippet by End-use
    4. Market Snippet by Region
  4. Global Botulinum Toxin  Market – Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. Growing Research and Development Initiatives to Expand the Therapeutic Applications of Botulinum Toxin
        2. Increasing Demand for Aesthetic Procedures
      2. Restraints:
        1. Adverse effects Associated with Botulinum Toxin
      3. Opportunity
      4. Impact Analysis
  5. Global Botulinum Toxin Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Pricing Analysis
    4. Regulatory Analysis
    5. Reimbursement Analysis
    6. Unmet Needs
  6. Global Botulinum Toxin  Market – COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Global Botulinum Toxin Market – By Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
      2. Market Attractiveness Index, By Type Segment
    2. Botulinum toxin type A*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Botulinum toxin type B
    4. Botulinum toxin type C
    5. Botulinum toxin type D
    6. Botulinum toxin type E
    7. Botulinum toxin type F
    8. Botulinum toxin type G
  8. Global Botulinum Toxin Market – By Application

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      2. Market Attractiveness Index, By Application
    2. Cosmetic Applications*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
      3. Glabellar lines
      4. Lateral canthal lines (crow's feet)
      5. Forehead Lines
      6. Other
    3. Non-Cosmetic Applications
      1. Dystonia
      2. Chronic migraine
      3. Ophthalmologic disorders
      4. Other
  9. Global Botulinum Toxin Market – By End-use

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-use Segment
      2. Market Attractiveness Index, By End-use Segment
    2. Hospital *
      1. Introduction
      2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Dermatology Clinics
    4. Spas & cosmetic centers
  10. Global Botulinum Toxin Market – By Region

    1. Introduction
      1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-use
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-use
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-use
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-use
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-use
  11. Global Botulinum Toxin Market – Competitive Landscape

    1. Key Developments and Strategies
    2. Company Share Analysis
    3. Product Benchmarking
    4. List of key companies to watch
    5. List of the company with disruptive technology
    6. List of start-up companies
  12. Global Botulinum Toxin Market- Company Profiles

    1. Allergan Plc.*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Eisai Co., Ltd
    3.  Hugel, Inc.
    4.  Hugh Source International Ltd.
    5. Ipsen
    6.  Medytox, Inc.
    7.  Merz Pharma
    8. Evolus, Inc.
    9.  AbbVie
    10. Revance Therapeutics, Inc(*LIST NOT EXHAUSTIVE)
  13. Global Botulinum Toxin Market – DataM

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables & Figures

List of Tables

Table 01 Global Botulinum Toxin Market Value, By Type, 2020, 2024 & 2028($ Million)             

Table 02 Global Botulinum Toxin Market Value, By Application, 2020, 2024 & 2028($ Million)            

Table 03 Global Botulinum Toxin Market Value, By End-use, 2020, 2024 & 2028($ Million)            

Table 04 Global Botulinum Toxin Market Value, By Region, 2020, 2024 & 2028($ Million)            

Table 05 Global Botulinum Toxin Market Value, By Type, 2020, 2024 & 2028($ Million)             

Table 06 Global Botulinum Toxin Market Value, By Type, 2018-2028 ($ Million)              

Table 07 Global Botulinum Toxin Market Value, By Application, 2020, 2024 & 2028($ Million)            

Table 08 Global Botulinum Toxin Market Value, By Application, 2018-2028 ($ Million)             

Table 09 Global Botulinum Toxin Market Value, By End-use, 2020, 2024 & 2028($ Million)            

Table 10 Global Botulinum Toxin Market Value, By End-use, 2018-2028 ($ Million)             

Table 11 Global Botulinum Toxin Market Value, By Region, 2020, 2024 & 2028($ Million)            

Table 12 Global Botulinum Toxin Market Value, By Region, 2018-2028 ($ Million)             

Table 13 North America Botulinum Toxin Market Value, By Type, 2018-2028 ($ Million)             

Table 14 North America Botulinum Toxin Market Value, By Application, 2018-2028 ($ Million)          

Table 15 North America Botulinum Toxin Market Value, By End-use, 2018-2028 ($ Million)       

Table 16 North America Botulinum Toxin Market Value, By Country, 2018-2028 ($ Million)       

Table 17 South America Botulinum Toxin Market Value, By Type, 2018-2028 ($ Million)             

Table 18 South America Botulinum Toxin Market Value, By Application, 2018-2028 ($ Million)          

Table 19 South America Botulinum Toxin Market Value, By End-use, 2018-2028 ($ Million)       

Table 20 South America Botulinum Toxin Market Value, By Country, 2018-2028 ($ Million)       

Table 21 Europe Botulinum Toxin Market Value, By Type, 2018-2028 ($ Million)              

Table 22 Europe Botulinum Toxin Market Value, By Application, 2018-2028 ($ Million)             

Table 23 Europe Botulinum Toxin Market Value, By End-use, 2018-2028 ($ Million)             

Table 24 Europe Botulinum Toxin Market Value, By Country, 2018-2028 ($ Million)             

Table 25 Asia-Pacific Botulinum Toxin Market Value, By Type, 2018-2028 ($ Million)             

Table 26 Asia-Pacific Botulinum Toxin Market Value, By Application, 2018-2028 ($ Million)       

Table 27 Asia-Pacific Botulinum Toxin Market Value, By End-use, 2018-2028 ($ Million)             

Table 28 Asia-Pacific Botulinum Toxin Market Value, By Country, 2018-2028 ($ Million)             

Table 29 Middle East & Africa Botulinum Toxin Market Value, By Type, 2018-2028 ($ Million)          

Table 30 Middle East & Africa Botulinum Toxin Market Value, By Application, 2018-2028 ($ Million)              

Table 31 Middle East & Africa Botulinum Toxin Market Value, By End-use, 2018-2028 ($ Million)          

Table 32 Allergan: Overview      

Table 33 Allergan: Product Portfolio     

Table 34 Allergan: Key Developments  

Table 35 Eisai Co.: Overview     

Table 36 Eisai Co.: Product Portfolio    

Table 37 Eisai Co.: Key Developments 

Table 38 Hugel, Inc.: Overview 

Table 39 Hugel, Inc.: Product Portfolio

Table 40 Hugel, Inc.: Key Developments           

Table 41 Hugh Source International Ltd.,: Overview   

Table 42 Hugh Source International Ltd.,: Product Portfolio  

Table 43 Hugh Source International Ltd.,: Key Developments              

Table 44 Ipsen: Overview            

Table 45 Ipsen: Product Portfolio           

Table 46 Ipsen: Key Developments        

Table 47 Medytox: Overview     

Table 48 Medytox: Product Portfolio    

Table 49 Medytox: Key Developments 

Table 50 Merz Pharma: Overview           

Table 51 Merz Pharma: Product Portfolio         

Table 52 Merz Pharma: Key Developments      

Table 53 Evolus, Inc: Overview

Table 54 Evolus, Inc: Product Portfolio              

Table 55 Evolus, Inc: Key Developments           

Table 56 AbbVie: Overview        

Table 57 AbbVie: Product Portfolio       

Table 58 AbbVie: Key Developments    

Table 59 Revance Therapeutics, Inc: Overview

Table 60 Revance Therapeutics, Inc: Product Portfolio              

Table 61 Revance Therapeutics, Inc: Key Developments               

 

List of Figures

Figure 01 Global Botulinum Toxin Market Share, By Type, 2020 & 2028 (%)

Figure 02 Global Botulinum Toxin Market Share, By Application, 2020 & 2028 (%)            

Figure 03 Global Botulinum Toxin Market Share, By End-use, 2020 & 2028 (%)              

Figure 04 Global Botulinum Toxin Market Share, By Region, 2020 & 2028 (%)              

Figure 05 Global Botulinum Toxin Market Value, 2018-2028 ($ Million)         

Figure 06 Global Botulinum Toxin Market Y-o-Y Growth, By Type, 2018-2028 (%)            

Figure 07 Botulinum toxin type A: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)          

Figure 08 Botulinum toxin type B: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)          

Figure 09 Botulinum toxin type C: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)          

Figure 10 Botulinum toxin type D: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)          

Figure 11 Botulinum toxin type E: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)          

Figure 12 Botulinum toxin type F: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)          

Figure 13 Botulinum toxin type G: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)          

Figure 14 Global Botulinum Toxin Market Y-o-Y Growth, By Application, 2018-2028 (%)          

Figure 15 "Cosmetic Applications: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)"         

Figure 16 "Non-Cosmetic Applications: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)"            

Figure 17 Global Botulinum Toxin Market Y-o-Y Growth, By End-use, 2018-2028 (%)       

Figure 18 "Hospitals: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)"           

Figure 19 Dermatology Clinics: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)          

Figure 20 Spas & cosmetic centers: Global Botulinum Toxin Market Value, 2018-2028 ($ Million)               

Figure 21 Global Botulinum Toxin Market Y-o-Y Growth, By Region, 2018-2028 (%)       

Figure 22 North America Botulinum Toxin Market Value, 2018-2028 ($ Million)              

Figure 23 North America Botulinum Toxin Market Share, By Type, 2020 & 2028 (%)       

Figure 24 North America Botulinum Toxin Market Share, By Application, 2020 & 2028 (%)          

Figure 25 North America Botulinum Toxin Market Share, By End-use, 2020 & 2028 (%)          

Figure 26 North America Botulinum Toxin Market Share, By Country, 2020 & 2028 (%)          

Figure 27 South America Botulinum Toxin Market Value, 2018-2028 ($ Million)              

Figure 28 South America Botulinum Toxin Market Share, By Type, 2020 & 2028 (%)       

Figure 29 South America Botulinum Toxin Market Share, By Application, 2020 & 2028 (%)          

Figure 30 South America Botulinum Toxin Market Share, By End-use, 2020 & 2028 (%)          

Figure 31 South America Botulinum Toxin Market Share, By Country, 2020 & 2028 (%)          

Figure 32 Europe Botulinum Toxin Market Value, 2018-2028 ($ Million)       

Figure 33 Europe Botulinum Toxin Market Share, By Type, 2020 & 2028 (%)              

Figure 34 Europe Botulinum Toxin Market Share, By Application, 2020 & 2028 (%)       

Figure 35 Europe Botulinum Toxin Market Share, By End-use, 2020 & 2028 (%)              

Figure 36 Europe Botulinum Toxin Market Share, By Country, 2020 & 2028 (%)              

Figure 38 Asia-Pacific Botulinum Toxin Market Value, 2018-2028 ($ Million)              

Figure 39 Asia-Pacific Botulinum Toxin Market Share, By Type, 2020 & 2028 (%)            

Figure 40 Asia-Pacific Botulinum Toxin Market Share, By Application, 2020 & 2028 (%)          

Figure 41 Asia-Pacific Botulinum Toxin Market Share, By End-use, 2020 & 2028 (%)       

Figure 42 Asia-Pacific Botulinum Toxin Market Share, By Country, 2020 & 2028 (%)       

Figure 43 Middle East & Africa Botulinum Toxin Market Value, 2018-2028 ($ Million)             

Figure 44 Middle East & Africa Botulinum Toxin Market Share, By Type, 2020 & 2028 (%)          

Figure 45 Middle East & Africa Botulinum Toxin Market Share, By Application, 2020 & 2028 (%)         

Figure 46 Middle East & Africa Botulinum Toxin Market Share, By End-use, 2020 & 2028 (%)      

Figure 47 Allergan: Financials    

Figure 48 Eisai Co.: Financials   

Figure 49 Hugel, Inc.: Financials              

Figure 50 Hugh Source International Ltd.,: Financials 

Figure 51 Ipsen: Financials          

Figure 52 Medytox: Financials   

Figure 53 Merz Pharma: Financials         

Figure 54 Evolus, Inc: Financials             

Figure 55 AbbVie: Financials      

Figure 56 Revance Therapeutics, Inc: Financials        

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest